Home/Response Pharmaceuticals/Eric Keller, J.D.
EK

Eric Keller, J.D.

Chief Executive Officer, Founder & Chairman

Response Pharmaceuticals

Response Pharmaceuticals Pipeline

DrugIndicationPhase
RDX-002Antipsychotic-Induced Weight Gain (AIWG)Phase 1b